PCSK9 Inhibitors and Cardiovascular Risk: Do They Really Reduce Heart Attacks and Strokes?

Dr. Kumar’s Take:

A recent meta-analysis reviewed the effects of PCSK9 inhibitors, a class of cholesterol-lowering drugs, on cardiovascular risk. The study included over 76,000 patients and found that while these drugs do lower LDL cholesterol, their ability to prevent heart attacks and strokes appears modest at best. The study suggests alirocumab may slightly lower the risk of death, but the overall benefits on mortality and cardiovascular events are small and limited to very high-risk patients.

Read more

Are Statins as Effective and Safe as We’ve Been Told? A Critical Review

Dr. Kumar’s Take:

A 2015 paper challenges the mainstream narrative about statins. While statins effectively lower cholesterol, the study argues that their actual impact on preventing heart disease and death is minimal. The authors highlight how statistical manipulation has exaggerated benefits while side effects are downplayed. This review breaks down the study’s findings and what they mean for you.

Brief Summary:

The paper claims that statins’ benefits have been overstated due to the use of relative risk reduction (RRR) instead of absolute risk reduction (ARR) in clinical trials. While RRR makes statins appear highly effective, ARR shows that only about 1-2% of patients actually benefit.

Read more

Do Statins Contribute to Heart Disease? A Review of a Controversial Study

Dr. Kumar’s Take:

A 2015 study published in Expert Review of Clinical Pharmacology challenges the long-standing belief that statins are universally beneficial for heart health. The authors argue that statins might inadvertently contribute to atherosclerosis and heart failure by disrupting essential physiological pathways. While this claim is controversial, understanding the mechanisms at play can help individuals make informed choices about their heart health.

Brief Summary:

The study explores the unintended effects of statins on cardiovascular health. The authors suggest that statins, while effective at lowering LDL cholesterol, may also:

Read more

Does Cholesterol Really Cause Atherosclerosis? A Study From 1961 Raises Questions

Dr. Kumar’s Take:

It might surprise you to learn that scientists questioned the cholesterol-heart disease link as early as the 1960s. This study, conducted in India, examined 200 autopsies to determine if higher serum cholesterol levels correlated with more severe atherosclerosis. The results? No significant relationship was found once age was accounted for. This suggests that cholesterol alone may not be the driving factor behind clogged arteries.

The study serves as an early example of the ongoing debate over cholesterol’s role in heart disease. While modern research continues to evolve, this historical study reminds us that the “cholesterol causes atherosclerosis” narrative was never as clear-cut as it seemed.

Read more

Does High LDL-C Help Elderly People Live Longer? A Review of 19 Studies

Dr. Kumar’s Take:

A systematic review of 19 cohort studies raises serious questions about the conventional approach to cholesterol management in elderly individuals. The study found that in 92% of participants, those with the highest levels of low-density lipoprotein cholesterol (LDL-C) lived the longest. No study showed the opposite trend. This challenges the widely accepted “cholesterol hypothesis” that LDL-C is inherently harmful and suggests that guidelines recommending statin therapy for elderly people may need urgent reevaluation.

Read more

Does Rosuvastatin Prevent Heart Attacks? A Critical Review of the JUPITER Trial

Dr. Kumar’s Take:

The JUPITER trial found that rosuvastatin significantly reduced heart attacks and strokes in individuals with elevated C-reactive protein (CRP - a marker of inflammation) but normal LDL cholesterol. However, the absolute risk reductions were modest, raising questions about the superiority of statins over lifestyle changes. Additionally, industry funding, conflicts of interest, and the early trial termination suggest a need for caution when interpreting results. One intriguing aspect is whether statins’ anti-inflammatory effects, rather than LDL lowering, contributed to the observed benefits.

Read more

Should Healthy Men Take Statins? A Critical Review

Dr. Kumar’s Take:

Should healthy men with high cholesterol take statins? According to this critical review, the answer is no. While statins are effective for people with existing heart disease, the benefits in otherwise healthy individuals are questionable. The research reviewed shows no increase in life expectancy from statin use, while the risks—including muscle pain, cognitive decline, diabetes, and fatigue—are significant. Instead of relying on statins, men without heart disease should focus on lifestyle changes like diet and exercise for long-term heart health.

Read more

Does Rosuvastatin Prevent Heart Disease in Healthy People with Intermediate Risk? A Look at the HOPE-3 Trial

Dr. Kumar’s Take:

The HOPE-3 trial found that rosuvastatin (10 mg daily) reduced cardiovascular risk by 24%, even in people without prior heart disease. However, the absolute benefit was small—only 1 fewer event per 91 people treated over 5.6 years. Those who couldn’t tolerate statins were excluded, and AstraZeneca funded the study, which raises concerns about bias. Also, the raw data isn’t publicly available, limiting independent verification. For people at moderate risk, a statin may help, but the decision should be individualized.

Read more

Coconuts, Cholesterol, and Heart Health: What a Study on Polynesian Atolls Reveals

Dr. Kumar’s Take:

A study from 1981 examined how a diet high in saturated fat from coconuts affected cholesterol levels and the incidence of heart disease in two Polynesian populations. High saturated fats from coconuts led to increased cholesterol levels with no evidence of heart disease. This suggests that natural, whole-food sources of saturated fat are not harmful. Studies like this challenge common beliefs about coconut oil, saturated fats, and heart health.

Actionable tip: If you’re consuming saturated fats from coconut, focus on unprocessed, whole-food sources like fresh coconut and coconut milk, rather than sweetened or refined versions.

Read more

Should Low-Risk Patients Take Statins? A Critical Review

Dr. Kumar’s Take:

Many people are prescribed statins to lower cholesterol and reduce the risk of heart attacks and strokes. But do these drugs actually help those who have a low risk of heart disease? A recent review challenges the routine use of statins in low-risk patients, revealing minimal benefits but significant side effects like muscle pain and increased diabetes risk.

Actionable Takeaway:

If your doctor suggests statins but your 10-year heart disease risk is under 20%, ask about lifestyle changes first. A Mediterranean diet, exercise, and avoiding smoking may provide similar or better protection without the side effects.

Read more

Is High LDL-C Protective in the Elderly? A Review of the Evidence

Dr. Kumar’s Take:

A groundbreaking systematic review published in BMJ Open challenges conventional wisdom about cholesterol and heart health. The study found that in people over 60, higher levels of LDL cholesterol (LDL-C) were associated with lower mortality. This raises important questions about whether lowering LDL-C with medication is beneficial in older adults. If you’re over 60 and concerned about cholesterol, it may be time to re-evaluate the role of LDL-C in health and longevity.

Read more

LDL Cholesterol: Finding the Right Balance for Heart Health

Dr. Kumar’s Take

This study looked at how different levels of LDL cholesterol affect our chance of dying from any cause and from heart-related problems. It found that having very low or very high LDL can be risky, but in different ways.

• Very low LDL (<70 mg/dL) was linked to a higher risk of strokes and overall heart-related deaths (cardiovascular mortality).
• Very high LDL (≥190 mg/dL) was linked to a higher risk of heart disease (CHD) and overall heart-related deaths, but it did not show an increase in deaths from any cause (all-cause mortality).

In other words, both very low and very high LDL levels increase the risk of heart problems. However, very high LDL does not increase the overall chance of dying when compared to moderate LDL levels.

Read more